142 related articles for article (PubMed ID: 7444164)
1. Flow microfluorometric analysis of the cell cycle phase cytotoxicity of ARA-C.
Hromas RA; Markel DE; Scholes VE
Res Commun Chem Pathol Pharmacol; 1980 Nov; 30(2):365-8. PubMed ID: 7444164
[TBL] [Abstract][Full Text] [Related]
2. S1-phase cells of the leukemic cell cycle sensitive to 1-beta-D-arabinofuranosylcytosine at a high-dose level.
Smets LA; Homan-Blok J
Cancer Res; 1985 Jul; 45(7):3113-7. PubMed ID: 4005848
[TBL] [Abstract][Full Text] [Related]
3. Paradoxical effect of cytosine arabinoside on mouse leukemia cell line L1210 cells.
Nakayama T; Sakamoto S; Sassa S; Suzuki S; Kudo H; Nagasawa H
Anticancer Res; 2005; 25(1A):157-60. PubMed ID: 15816533
[TBL] [Abstract][Full Text] [Related]
4. Cell kinetic studies of the cytostatic and cytocidal effect of 1-beta-D-arabinofuranosylcytosine on the L1210 ascites tumor.
Fietkau R; Friede H; Maurer-Schultze B
Cancer Res; 1984 Mar; 44(3):1105-13. PubMed ID: 6692397
[TBL] [Abstract][Full Text] [Related]
5. Detection of cytosine arabinoside resistant cells at low frequency using the bromodeoxyuridine/DNA assay.
Waldman FM; Dolbeare F; Gray JW
Cytometry; 1985 Nov; 6(6):657-62. PubMed ID: 4064845
[TBL] [Abstract][Full Text] [Related]
6. Microfluorometric investigations on the cell cycle progression of experimental ascites tumors treated with alkaloidic drugs.
Stöhr M; Fischinger W
Arzneimittelforschung; 1978; 28(6):977-81. PubMed ID: 582007
[TBL] [Abstract][Full Text] [Related]
7. Flow microfluorimetric analysis of sensitive and resistant leukemia L1210 following 1-beta-D-arabinofuranosylcytosine in vivo.
Alabaster O; Bunnag B
Cancer Res; 1976 Aug; 36(8):2744-9. PubMed ID: 1277184
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and cytokinetic modulation of L1210 and HL-60 cells by hydroxyurea and effect on 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity.
Rauscher F; Cadman E
Cancer Res; 1983 Jun; 43(6):2688-93. PubMed ID: 6189585
[TBL] [Abstract][Full Text] [Related]
9. Quantitative analysis of the cytokinetic response of KHT tumors in vivo to 1-beta-D-arabinofuranosylcytosine.
Pallavicini MG; Gray JW; Folstad LJ
Cancer Res; 1982 Aug; 42(8):3125-31. PubMed ID: 7093956
[TBL] [Abstract][Full Text] [Related]
10. Synchronization of L1210 leukemia with hydroxyurea infusion and the effect of subsequent pulse dose chemotherapy.
Moran RE; Straus MJ
Cancer Treat Rep; 1980 Jan; 64(1):81-6. PubMed ID: 7379059
[TBL] [Abstract][Full Text] [Related]
11. Induction of S phase cell arrest and caspase activation by polysaccharide peptide isolated from Coriolus versicolor enhanced the cell cycle dependent activity and apoptotic cell death of doxorubicin and etoposide, but not cytarabine in HL-60 cells.
Hui KP; Sit WH; Wan JM
Oncol Rep; 2005 Jul; 14(1):145-55. PubMed ID: 15944782
[TBL] [Abstract][Full Text] [Related]
12. Effects of chartreusin on cell survival and cell cycle progression.
Bhuyan BK; Robinson MI; Shugars KD; Bono VH; Dion RL
Cancer Res; 1978 Sep; 38(9):2734-9. PubMed ID: 567096
[TBL] [Abstract][Full Text] [Related]
13. Increased activation of 1-beta-D-arabinofuranosylcytosine by hydroxyurea in L1210 cells.
Walsh CT; Craig RW; Agarwal RP
Cancer Res; 1980 Sep; 40(9):3286-92. PubMed ID: 7427943
[TBL] [Abstract][Full Text] [Related]
14. Use of cell-cycle information in the preparation of drug combinations: results with cytosine arabinoside plus actinomycin D1,2.
Bhuyan BK; Fraser TJ; Day KJ
Cancer Treat Rep; 1976 Dec; 60(12):1813-8. PubMed ID: 1036090
[TBL] [Abstract][Full Text] [Related]
15. Combination chemotherapy involving alpha-difluoromethylornithine and 1-beta-D-arabinofuranosylcytosine in murine L1210 leukemia.
Prakash NJ; Sunkara PS
Cancer Res; 1983 Jul; 43(7):3192-6. PubMed ID: 6406054
[TBL] [Abstract][Full Text] [Related]
16. Relationship between incorporation of 9-beta-D-arabinofuranosyladenine in L 1210 DNA and cytotoxicity.
Kufe DW; Major PP; Munroe D; Egan M; Herrick D
Cancer Res; 1983 May; 43(5):2000-4. PubMed ID: 6831429
[TBL] [Abstract][Full Text] [Related]
17. Dysregulation of the cyclin-dependent kinase inhibitor p21WAF1/CIP1/MDA6 increases the susceptibility of human leukemia cells (U937) to 1-beta-D-arabinofuranosylcytosine-mediated mitochondrial dysfunction and apoptosis.
Wang Z; Van Tuyle G; Conrad D; Fisher PB; Dent P; Grant S
Cancer Res; 1999 Mar; 59(6):1259-67. PubMed ID: 10096557
[TBL] [Abstract][Full Text] [Related]
18. Administration of low-dose cytarabine results in immediate S-phase arrest and subsequent activation of cell cycling in murine stem cells.
van Pelt K; de Haan G; Vellenga E; Daenen SM
Exp Hematol; 2005 Feb; 33(2):226-31. PubMed ID: 15676217
[TBL] [Abstract][Full Text] [Related]
19. [Detection of the resistance to Ara-C blast cells in acute myeloid leukemia using flow cytometry].
Lacombe F; Belloc F; Dumain P; Puntous M; Cony-Makhoul P; Bernard P; Boisseau MR; Reiffers J
Bull Cancer; 1995; 82(5):349-56. PubMed ID: 7626842
[TBL] [Abstract][Full Text] [Related]
20. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).
Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD
Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
